Jupiter Neurosciences (JUNS) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.12

Volume / Avg.

3.38K / 118.22K

Day Range

$1.12 - $1.14

52 Wk Range

0.51 - 19.51

Market Cap

$38.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.2%

Days to Cover

Recent Jupiter Neurosciences Inc News

Partner Content

From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon

Partner Content

Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia – And A Range Of Celebs From Athletes To Scientists Are Customers

Partner Content

Jupiter Neurosciences CEO And President Talk About The Power Of JOTROL And The Launch Of Its Longevity Consumer Line With Benzinga

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

$1.12

Volume / Avg.

3.38K / 118.22K

Day Range

$1.12 - $1.14

52 Wk Range

0.51 - 19.51

Market Cap

$38.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.2%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry